Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma
Condition(s):Lymphoma, Non-Hodgkin; Child, OnlyLast Updated:January 5, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Non-Hodgkin; Child, OnlyLast Updated:January 5, 2024Completed
Condition(s):ADHD; Child, OnlyLast Updated:August 27, 2021Unknown status
Condition(s):Child, Only; Quality of LifeLast Updated:January 30, 2024Completed
Condition(s):Children, Only; AdolescentLast Updated:March 1, 2021Unknown status
Condition(s):Cardiopulmonary Arrest With Successful Resuscitation; Child, OnlyLast Updated:June 19, 2020Unknown status
Condition(s):Participation, Patient; Child, OnlyLast Updated:May 27, 2021Completed
Condition(s):Obesity; Child, OnlyLast Updated:October 12, 2023Active, not recruiting
Condition(s):Headache; Child, OnlyLast Updated:February 1, 2022Unknown status
Condition(s):Congenital Heart Disease; Children, OnlyLast Updated:October 7, 2022Not yet recruiting
Condition(s):Fever; Child, OnlyLast Updated:September 6, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.